Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
25.30
+1.16 (4.81%)
At close: Sep 30, 2026
| Market Cap | 9.28B -18.1% |
| Revenue (ttm) | 338.44M +348.4% |
| Net Income | -562.52M |
| EPS | -1.53 |
| Shares Out | 366.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,602,509 |
| Open | 24.29 |
| Previous Close | 24.14 |
| Day's Range | 24.14 - 25.62 |
| 52-Week Range | 20.07 - 32.82 |
| Beta | 0.65 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 31, 2026 |